13F HOLDINGS REPORT
SECTOR GAMMA AS
Quarter ended Q3 2024 · Filed November 13, 2024 · Accession 0000945621-24-000926
Total Value
$329.6M
Positions
29
Other Managers
0
Confidential Omitted
No
Holdings (29)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | BRISTOL-MYERS SQUIBB CO | CELG-RI | 602,000 | $31.1M | 9.45% |
| 2 | MEDTRONIC PLC | MDT | 334,890 | $30.2M | 9.15% |
| 3 | GILEAD SCIENCES INC | GILD | 289,163 | $24.2M | 7.36% |
| 4 | PFIZER INC | PFE | 820,000 | $23.7M | 7.20% |
| 5 | CVS HEALTH CORP | CVS | 302,000 | $19.0M | 5.76% |
| 6 | BECTON DICKINSON & CO | BDX | 77,280 | $18.6M | 5.65% |
| 7 | INCYTE CORP | INCY | 259,000 | $17.1M | 5.19% |
| 8 | BAXTER INTL INC | 071813109 | 385,000 | $14.6M | 4.44% |
| 9 | ELEVANCE HEALTH INC | ELV | 26,279 | $13.7M | 4.15% |
| 10 | BIOMARIN PHARMACEUTICAL INC | BMRN | 190,348 | $13.4M | 4.06% |
| 11 | CARDINAL HEALTH INC | CAH | 117,098 | $12.9M | 3.93% |
| 12 | ZIMMER BIOMET HOLDINGS INC | ZBH | 106,000 | $11.4M | 3.47% |
| 13 | BRUKER CORP | BRKRP | 158,970 | $11.0M | 3.33% |
| 14 | QIAGEN NV | QGEN | 223,124 | $10.2M | 3.09% |
| 15 | GE HEALTHCARE TECHNOLOGIES I | GEHC | 106,700 | $10.0M | 3.04% |
| 16 | IONIS PHARMACEUTICALS INC | IONS | 210,842 | $8.4M | 2.56% |
| 17 | CENTENE CORP DEL | CNC | 95,000 | $7.2M | 2.17% |
| 18 | EDWARDS LIFESCIENCES CORP | EW | 106,153 | $7.0M | 2.13% |
| 19 | BIOGEN INC | BIIB | 35,166 | $6.8M | 2.07% |
| 20 | BIO RAD LABS INC | 090572207 | 16,829 | $5.6M | 1.71% |
| 21 | AMGEN INC | AMGN | 16,000 | $5.2M | 1.56% |
| 22 | BIONTECH SE | BNTX | 40,000 | $4.8M | 1.44% |
| 23 | TENET HEALTHCARE CORP | THC | 26,361 | $4.4M | 1.33% |
| 24 | UNIVERSAL HLTH SVCS INC | 913903100 | 17,627 | $4.0M | 1.22% |
| 25 | HUMANA INC | HUM | 12,000 | $3.8M | 1.15% |
| 26 | LANTHEUS HLDGS INC | LNTH | 31,712 | $3.5M | 1.06% |
| 27 | AGIOS PHARMACEUTICALS INC | AGIO | 67,908 | $3.0M | 0.92% |
| 28 | ALKERMES PLC | ALKS | 100,000 | $2.8M | 0.85% |
| 29 | LEGEND BIOTECH CORP | LEGN | 38,762 | $1.9M | 0.57% |